SCHEMBL14083596

SCHEMBL14083596

O=C(Nc1ccc(N2CCOCC2)cc1)c1ccc(-c2ncccc2Cl)cc1F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.53
▸ RAB9A P51151 6/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ HPGD P15428 1/20 0.52
▸ TRPV1 Q8NER1 1/20 0.52
▸ MAPT P10636 5/20 0.51
▸ PDE4A P27815 1/20 0.49
▸ PDE4B Q07343 1/20 0.49
▸ PDE4C Q08493 1/20 0.49
▸ PDE4D Q08499 1/20 0.49
▸ PDE7A Q13946 1/20 0.49
▸ ABCB1 P08183 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ TP53 P04637 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ FGFR3 P22607 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ HCRTR1 O43613 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083351 0.89 ALDH1A1 (0.53) ALDH1A1RAB9ANPC1TRPV1MAPT
SCHEMBL14083188 0.87 MAPT (0.52) ALDH1A1RAB9ANPC1MAPTABCB1
SCHEMBL14083543 0.84 TRPV1 (0.63) ALDH1A1RAB9ANPC1TRPV1MAPT
SCHEMBL14082764 0.84 TRPV1 (0.62) ALDH1A1RAB9ANPC1TRPV1LMNA
SCHEMBL14083949 0.83 MAPT (0.58) ALDH1A1RAB9ANPC1TRPV1MAPT
SCHEMBL14083572 0.83 TRPV1 (0.60) TRPV1
SCHEMBL14083158 0.83 ABCB1 (0.56) ALDH1A1RAB9AMAPTPDE7AABCB1
SCHEMBL14083324 0.82 FGFR3 (0.47) ALDH1A1RAB9ANPC1MAPTABCB1
SCHEMBL14083575 0.82 TRPV1 (0.62) TRPV1HTT
SCHEMBL14083678 0.81 MAPT (0.55) ALDH1A1RAB9ANPC1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 ALDH1A1 1577/4885RAB9A 1914/4885NPC1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback